NadiAIGlobal AI news. Concise. Clear. Easy to follow.
Advanced nonanimal methods (NAMs) such as organ‑on‑a‑chip systems, organoids, and computational models are maturing and are being adopted by some drug developers and regulators. But validation, standardization, data sharing, funding, and cultural change remain major barriers to wider use.
Emerson argues that increasing system complexity demands test and verification be integrated throughout engineering workflows rather than treated as a final checkpoint. Connected measurement platforms and contextual data are presented as necessary so AI can highlight multi‑system interactions and help engineers find root causes faster.
